Publications by authors named "C Geredeli"

Claim this Profile
T
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar, Oktay Halit Aktepe, Emrah Eraslan, Cağlayan Geredeli

BMC Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer.
Zuhat Urakçı, Muhammet Ali Kaplan, Zeynep Oruç, Mahmut Gümüş, Doğan Uncu, Çağlayan Geredeli

Ann Ital Chir· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patients.
Dilek Çağlayan, Mehmet Zahid Koçak, Çağlayan Geredeli, Muhammed Mustafa Atcı, Ali Murat Tatlı

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.
Mehmet Fatih Ozbay, Hakan Harputluoglu, Mustafa Karaca, Omer Tekin, Mehmet Ali Nahit Şendur, Caglayan Geredeli

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in gastric cancer: Pathological regression grade and its relationship to clinical outcome.
Muhammed M Atci, Saban Secmeler, Abdullah Sakin, Serdar Arici, Orcun Can, Caglayan Geredeli

Indian J Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis